Iron status influences mitochondrial disease progression in Complex I-deficient mice
eLife · 2023
DOI: 10.7554/elife.75825 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von C J Kelly und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine & Pathology, University of Washington, Seattle, United States. Hauptthemen laut MEDLINE: Leigh Disease, Mitochondrial Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Mitochondrial dysfunction caused by aberrant Complex I assembly and reduced activity of the electron transport chain is pathogenic in many genetic and age-related diseases. Mice missing the Complex I subunit NADH dehydrogenase [ubiquinone] iron-sulfur protein 4 (NDUFS4) are a leading mammalian model of severe mitochondrial disease that exhibit many characteristic symptoms of Leigh Syndrome including oxidative stress, neuroinflammation, brain lesions, and premature death. NDUFS4 knockout mice have decreased expression of nearly every Complex I subunit. As Complex I normally contains at least 8 iron-sulfur clusters and more than 25 iron atoms, we asked whether a deficiency of Complex I may lead to iron perturbations, thereby accelerating disease progression. Consistent with this, iron supplementation accelerates symptoms of brain degeneration in these mice, while iron restriction delays the onset of these symptoms, reduces neuroinflammation, and increases survival. NDUFS4 knockout mice display signs of iron overload in the liver including increased expression of hepcidin and show changes in iron-responsive element-regulated proteins consistent with increased cellular iron that were prevented by iron restriction. These results suggest that perturbed iron homeostasis may contribute to pathology in Leigh Syndrome and possibly other mitochondrial disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine & Pathology, University of Washington, Seattle, United States.
ORCID-Profile: Matt Kaeberlein, Anthony S Grillo
Förderung
- NIH HHS
- NINDS NIH HHS
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Kelly, C. J., Couch, R. K., Ha, V. T., Bodart, C. M., Wu, J., Huff, S., Herrel, N. T., Kim, H. D., Zimmermann, A. O., Shattuck, J., Pan, Y. C., Kaeberlein, M., & Grillo, A. S. (2023). Iron status influences mitochondrial disease progression in Complex I-deficient mice. eLife. https://doi.org/10.7554/elife.75825
Vancouver
Kelly CJ, Couch RK, Ha VT, Bodart CM, Wu J, Huff S, et al. Iron status influences mitochondrial disease progression in Complex I-deficient mice. eLife. 2023. doi:10.7554/elife.75825
BibTeX
@article{Kelly2023,
author = {Kelly, C J and Couch, Reid K and Ha, Vivian T and Bodart, Camille M and Wu, Judy and Huff, Sydney and Herrel, Nicole T and Kim, Hyunsung D and Zimmermann, Azaad O and Shattuck, Jessica and Pan, Yu-Chen and Kaeberlein, Matt and Grillo, Anthony S},
title = {Iron status influences mitochondrial disease progression in Complex I-deficient mice},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.75825}
}
EUVIMED